|
|
|
|
|
|
|
|
|
|
Primary source |
Uniprot : Q2TAM9
|
Name |
Tumor suppressor candidate gene 1 protein
|
Alternative name(s) |
TSG-9
|
Synonym(s) |
TSG9
|
Organism |
Homo sapiens
|
Length |
212 aa
|
Protein existence |
---
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General annotation (Comments)
|
top
|
|
|
|
|
|
|
Tissue specificity
|
Widely expressed at low level. Expressed at higher level in testis, weakly expressed in muscle, colon, lung and spleen. Not detected in 3 non small cell lung carcinoma (NSCLC) cell lines with homozygous deletion of the 9p region, while it is down-regulated in 3 other tumor cell lines.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
With
|
Uniprot accession
|
IntAct
|
|
|
|
|
|
|
|
Alternative product(s)
|
top
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Feature key |
Position
|
Length
|
Description
|
Feature identifier
|
Region |
|
|
|
|
Coiled coil
|
73 - 117
|
45
|
Potential
|
Q2TAM9-COILED-73
|
Coiled coil
|
155 - 180
|
26
|
Potential
|
Q2TAM9-COILED-155
|
Compositional bias
|
9 - 56
|
48
|
Gly-rich
|
Q2TAM9-COMPBIAS-9
|
Natural variations |
|
|
|
|
Natural variant site
|
123 - 123
|
1
|
N -> D (in dbSNP:rs34498078)
|
VAR_037471
|
Amino acid modifications |
|
|
|
|
Modified residue
|
145 - 145
|
1
|
Phosphoserine
|
Q2TAM9-MOD_RES-145
|
Modified residue
|
153 - 153
|
1
|
Phosphoserine
|
Q2TAM9-MOD_RES-153
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
MGPMWRMRGG |
ATRRGSCCGG |
DGAADGRGPG |
RSGRARGGGS |
PSGGGGGVGW |
RGRADGARQQ |
LEERFADLAA |
SHLEAIRARD |
|
81 |
EWDRQNARLR |
QENARLRLEN |
RRLKRENRSL |
FRQALRLPGE |
GGNGTPAEAR |
RVPEEASTNR |
RARDSGREDE |
PGSPRALRAR |
|
161 |
LEKLEAMYRR |
ALLQLHLEQR |
GPRPSGDKEE |
QPLQEPDSGL |
RSRDSEPSGP |
WL |
|
|
|
|
|
|
|
|
|
|
|
|
>sp|Q2TAM9|TUSC1_human Tumor suppressor candidate gene 1 protein
MGPMWRMRGGATRRGSCCGGDGAADGRGPGRSGRARGGGSPSGGGGGVGWRGRADGARQQLEERFADLAASHLEAIRARD
EWDRQNARLRQENARLRLENRRLKRENRSLFRQALRLPGEGGNGTPAEARRVPEEASTNRRARDSGREDEPGSPRALRAR
LEKLEAMYRRALLQLHLEQRGPRPSGDKEEQPLQEPDSGLRSRDSEPSGPWL
|
|
|
| |
|
|
|
|
|